Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|May 2, 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic SyndromeAndreas Reiter, Guillaume Lefevre, Maria C Cid, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2018
Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic AsthmaHector Ortega, Steven W Yancey, Oliver N Keene, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2004
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costsRichard D O'Connor, Richard Stanford, Courtney Crim, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 10, 2017
Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotypeAnirban Basu, Anand Dalal, Giorgio Walter Canonica, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2017
Biomarkers for severe eosinophilic asthmaSteven W Yancey, Oliver N Keene, Frank C Albers, et al.
Respiratory Research|May 5, 2019
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysisCharlene M Prazma, Elisabeth H Bel, Robert G Price, et al.
ERJ Open Research|July 30, 2024
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placeboImran Howell, Daniel J Bratton, Gareth Hynes, et al.
Journal of Asthma and Allergy|June 24, 2021
Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic PhenotypesCharlene M Prazma, Marco Idzko, Jo Anne Douglass, et al.
Respiratory Research|March 5, 2022
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthmaStephanie Korn, Peter Howarth, Steven G Smith, et al.
Pageof 7